Oncotelic Therapeutics, Inc. (OTLC)
0.0594
0.00 (0.00%)
USD |
OTCM |
May 29, 16:00
Oncotelic Therapeutics EPS Diluted (Quarterly) : -0.0049 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Arcturus Therapeutics Holdings, Inc. | -0.9487 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Anika Therapeutics, Inc. | -0.3737 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.239M |
| Total Expenses (Quarterly) | 2.194M |
| Enterprise Value | 39.99M |
| Earnings Yield | 940.7% |
| Normalized Earnings Yield | -29.97 |